Skip to content

Impact of Exercise-derived Extracellular Vesicle in Blood and Physical Fitness Data in Overweight/Obesity Individuals

Exploring the Impact of Exercise-derived Extracellular Vesicle in Blood and Physical Fitness Data in Overweight/Obesity Individuals on Lymphangiogenesis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07312344
Acronym
Exercise
Enrollment
20
Registered
2025-12-31
Start date
2025-08-30
Completion date
2026-01-31
Last updated
2025-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity & Overweight

Keywords

Exercise, obesity, extracellular vesicle, clinical assessment, physical fitness

Brief summary

This project aims to study the effect of exercise in the obesity/overweight on the changes of physical fitness and blood components. This will provide novel knowledge for medical staffs, researchers, or companies developing alternative strategies for treating obesity/overweight, including drug development and health promotion project to delay or prevent the onset of the disease.

Interventions

DEVICEHigh-intensity interval training exercise on treadmill

High-intensity interval training exercise using 65% to 80% of heart rate max

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. Male or female individuals aged between 25-45 years 2. Thai nationality 3. Ability to walk or perform daily activities independently, without the use of an assistive device 4. Body mass index (BMI) between 25-35 kg/m² 5. Low physical activity levels or sedentary lifestyle based on the World Health Organization 2020 * The levels of moderate-intensity physical activity \< 150-300 minutes per week or the levels of vigorous-intensity physical activity \< 75-150 minutes per week * Moderate-intensity physical activity: fast walking and bicycling. Vigorous-intensity physical activity: running, aerobic dance, and swimming All participants are required to meet all inclusion criteria to be eligible for the research project.

Exclusion criteria

1. Smoking, substance abuse, or alcohol addiction 2. History of respiratory diseases, such as asthma, emphysema, or chronic obstructive pulmonary disease 3. History of cardiovascular diseases, such as coronary heart disease, aortic disease, arrhythmia, or deep vein thrombosis 4. History of high blood pressure (hypertension) 5. History of vestibular system diseases, such as Meniere's disease or otitis media 6. History of neurological disease, such as severe Parkinson's disease or stroke 7. History of previous lower limb surgery, such as hip, knee, or ankle replacement 8. History of musculoskeletal diseases, such as severe osteoarthritis 9. History of severe brain disease, such as dementia 10. Severe visual or hearing impairment 11. Have a cognitive and comprehensive impairment and unable to complete the intervention 12. Have high physical activity or regularly exercise

Design outcomes

Primary

MeasureTime frameDescription
Body heightPre-training (Day 1 before HIIT program)Body height (cm) will be measured by stadiometer
Blood component assessmentPre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program within 1 hour)Participant's blood components, e.g. extracellular vesicles, will be investigated by cell assays and proteomic analysis
Foot pressure distribution8 times: Day 1 (Before and after HIIT program), Day 4-7 (after HIIT program only), Day 18 (Before and after HIIT program)Foot pressure distribution will be measured using a treadmill (Zebris FDM-T Treadmill System, zebris Medical GmbH, Germany)
Facial and abdominal fat thickness measurementPre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)Facial and abdominal fat thickness and characteristics will be pictured and analyzed using ultrasound imaging
VO2maxPre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)VO2max parameter (ml/kg/min) will be examined using Cardio Pulmonary Exercise Test
Body compositionPre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)Body composition (%) will be measured by bioelectrical impedance analysis.
Heart ratePre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)Heart rate (beat/min) will be measured by pulse oximeters
Grip strengthPre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)Grip strength (kg) will be measured by hand grip dynamometer
Leg strengthPre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)Leg strength (kg) will be measured by back-leg-chest dynamometer
Body weightPre-training (Day 1 before HIIT program) and post-training (Day 18 after HIIT program)Body weight (kg) will be measured by weighing scale

Countries

Thailand

Contacts

Primary ContactOnaong Mee-inta, Ph.D.
onanong.mee@mahidol.ac.th(66)619922941
Backup ContactPhunsuk Kantha, Ph.D.
phunsuk.kan@mahidol.ac.th(66)932951646

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026